Biopharmaceutical manufacturer
Food and Drug Administration Simple Reauthorization Act of 2022 (S. 4535, FDASRA), S.4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDASLA) and the Food And Drug Amendments (HR 7667) - accelerated approval provisions - prescription drug and biosimilars user fee agreements - importation of prescription drugs - prescription drug pricing and access issues (Sanders amendments) 340B expansion generally H.R. 5376 - Build Back Better Act - drug pricing provisions S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 1 - SENATE
HAGGERTY POLICY SOLUTIONS
121 S Hudson St, Arlington, VA, 22204, US
JEANNE HAGGERTY JEANNE HAGGERTY